These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5041890)

  • 1. Serotonin content of platelet enriched plasma in Parkinson patients prior and during treatment with L-3,4-dihydroxyphenylalanine (L-DOPA).
    Yamaguchi K; Tomasi L; Cote LJ; Barrett R; Yahr MD
    Biochem Med; 1972 Jun; 6(3):210-5. PubMed ID: 5041890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the blood level of serotonin in Parkinson disease].
    Karimova MKh; Aleuov ShA
    Vopr Med Khim; 1988; 34(1):45-7. PubMed ID: 3130723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPA.
    Boullin DJ; O'Brien RA
    Br J Pharmacol; 1970 Aug; 39(4):779-88. PubMed ID: 5485151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of L-dopa on plasma free fatty acids and plasma glucose.
    Rivera-Calimlim L; Bianchine JR
    Metabolism; 1972 Jul; 21(7):611-7. PubMed ID: 5040916
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
    Pekkarinen A; Rinne UK; Salokangas R; Siirtola T; Sonninen V
    Acta Neurol Scand Suppl; 1972; 51():129-30. PubMed ID: 4514339
    [No Abstract]   [Full Text] [Related]  

  • 7. DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA.
    Hare TA; Beasley BL; Chambers RA; Boehme DH; Vogel WH
    Clin Chim Acta; 1973 May; 45(3):273-80. PubMed ID: 4708057
    [No Abstract]   [Full Text] [Related]  

  • 8. Bensarazid with L-dopa in the treatment of parkinson's disease.
    Van Wieringen A
    S Afr Med J; 1974 Feb; 48(6):206-9. PubMed ID: 4814495
    [No Abstract]   [Full Text] [Related]  

  • 9. An out-patient programme for L-Dopa therapy in Parkinson's disease.
    Hicks EP; Rischbieth RH
    Med J Aust; 1971 Oct; 2(14):701-6. PubMed ID: 5114187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
    Sakoda M; Kusaka T; Baba S; Shirakata S
    Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa in the treatment of post-surgical Parkinson patients.
    Wycis HT; Cunningham W; Kellett G; Spiegel EA
    J Neurosurg; 1970 Mar; 32(3):281-5. PubMed ID: 5416910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Theray of Parkinson-syndrome with Helfo-Dopa].
    Roeder F
    Med Klin; 1970 Nov; 65(45):1983-7. PubMed ID: 5520307
    [No Abstract]   [Full Text] [Related]  

  • 13. Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances.
    Lehmann J
    Acta Med Scand; 1973; 194(3):181-9. PubMed ID: 4746526
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms.
    Papavasiliou PS; McDowell FH; Wang YY; Rosal V; Miller ST
    Neurology; 1979 Feb; 29(2):194-200. PubMed ID: 571063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary report of Australian trials with L-dopa.
    Selby G
    Aust N Z J Med; 1971 May; 1():Suppl 1:48-56. PubMed ID: 4949275
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral L-dopa treatment of parkinsonism.
    Andén NE; Carlsson A; Kerstell J; Magnusson T; Olsson R; Roos BE; Steen B; Steg G; Svanborg A; Thieme G; Werdinius B
    Acta Med Scand; 1970 Apr; 187(4):247-55. PubMed ID: 4911257
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple gas chromatographic analysis of plasma dopa and dopamine.
    Mizuno Y
    Clin Chim Acta; 1977 Jan; 74(1):11-9. PubMed ID: 832410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism].
    Karimova MKh; Petelin LS; Aleuov ShA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):50-2. PubMed ID: 3213330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
    Massara F; Camanni F; Molinatti GM
    Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of human-growth-hormone secretion by L-dopa.
    Boyd AE; Lebovitz HE; Pfeiffer JB
    N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.